Quantcast
Home > Quotes > AQXP
x

Aquinox Pharmaceuticals, Inc. Common Stock (AQXP) Quote & Summary Data

AQXP 
$2.61
*  
0.02
0.76%
Get AQXP Alerts
*Delayed - data as of Oct. 17, 2018  -  Find a broker to begin trading AQXP now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    AQXP Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 2.67 / $ 2.60
Share Volume
137,737
50 Day Avg. Daily Volume
229,781
Previous Close
$ 2.63
52 Week High / Low
$ 16.90 / $ 1.96
Market Cap
61,432,530
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
137,737
50 Day Avg. Daily Volume:
229,781

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
Earnings Per Share (EPS):
$ -1.69

Trading Range

The current last sale of $2.61 is 33.16% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 2.67 $ 16.90
 Low: $ 2.60 $ 1.96

Company Description (as filed with the SEC)

We are a clinical-stage pharmaceutical company developing novel therapeutics for chronic urological conditions marked by inflammation and pain. Our lead drug candidate, rosiptor, is in Phase 3 development (Leadership 301 trial) for the treatment of patients with interstitial cystitis/bladder pain syndrome (IC/BPS), a condition for which there are currently few FDA approved and/or effective treatment options. We are focused on leveraging our library of novel compounds that activate SHIP1 (SH2-containing inositol-5'-phosphatase 1) to develop therapeutics for application in inflammation, inflammatory pain, and blood cancers. Rosiptor is a first-in-class, once-daily, oral treatment being studied for its effects on inflammation and inflammatory pain. Rosiptor has a novel mechanism of action, activating SHIP1, an enzyme that serves to down-regulate inflammation through its role in the PI3K signaling pathway.  ... More ...  


Risk Grade

Where does AQXP fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 2.66
Open Date:
Oct. 17, 2018
Close Price:
$ 2.61
Close Date:
Oct. 17, 2018

Consensus Recommendation

Analyst Info